CellEnvision ^Company

We are the first commercial Patient-Derived Explants (PDEs) platform used for profiling the response assessment and selection to cancer immunotherapy by developed of the single cell functional multi-omics analytical modules. Cellenvision is accelerating the discovery of identification & pathogenesis in oncology by revealing the true functional biology of every patient cell.